Protein Misfolding and Aggregation
蛋白质错误折叠和聚集
基本信息
- 批准号:7818210
- 负责人:
- 金额:$ 28.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAffectAffinityAmyotrophic Lateral SclerosisAntioxidantsBindingBinding SitesBiochemicalBiological AssayCell DeathCell physiologyComplexCuprozinc Superoxide DismutaseDependenceDiseaseDissociationEngineeringEnzymesErythrocytesEscherichia coliEventFamilial Amyotrophic Lateral SclerosisFeedbackFluorescenceGTP BindingGlutathioneGoalsGuanosine TriphosphateGuanosine Triphosphate PhosphohydrolasesHumanHydrogen PeroxideHyperactive behaviorInflammatoryKnowledgeLaboratoriesLeadLifeLinkMapsMeasuresModificationMutationN-terminalNADPH OxidaseNeurodegenerative DisordersNucleotidesOxidantsOxidation-ReductionOxidative StressOxidopamineParentsPathologyPhosphorylationPhysiologicalPlayProcessProteinsReactionRegulationRelative (related person)ReportingRoleSaccharomyces cerevisiaeSuperoxidesTechniquesWorkanalogbasecell motilitycytotoxicitydesigndimermutantoxidationpreventprotein misfoldingpublic health relevanceresearch study
项目摘要
DESCRIPTION (provided by applicant): The anti-oxidant enzyme Cu,Zn superoxide dismutase (SOD1) is associated with amyotrophic lateral sclerosis (ALS) through more than one hundred causative mutations. The Rac1 GTPase regulates oxidant levels through its role in regulating NADPH oxidase (Nox) activity. Intriguingly, SOD1 was recently shown to bind Rac1 in a nucleotide and redox dependent manner to regulate Rac1 activity. Furthermore, two ALS-associated mutations in SOD1 were shown to render the SOD1/Rac1 interaction insensitive to redox regulation, hypothesized to cause increased oxidant levels via Nox hyperactivity. However, this premise is based on limited qualitative results obtained from only two bacterially-derived mutants. Unlike natural SOD1 and human SOD1 expressed in S. cerevisiae, E. coli-derived human SOD1 lacks both N-terminal acetylation and adequate metallation. In addition, we recently found that 40-50% of SOD1 in human erythrocytes is modified by glutathione - a key player in the cellular redox state. Glutathionylation promotes SOD1 dimer dissociation, which is a necessary initiating event for SOD1 aggregation and a focus of the parent proposal. Here, we aim to provide a quantitative description of the SOD1/Rac1 interaction, and its proposed relationship to ALS, using SOD1 isolated from human erythrocytes and S. cerevisiae. We will use NMR and other biophysical techniques to characterize and quantify the Rac1/SOD1 interaction in the presence and absence of modifications and ALS-associated mutations in SOD1. The recent discovery that SOD1 interacts with the Nox complex through Rac1 provides a potential link between SOD1 (dys)function and downstream events leading to cell death. It is therefore important to delineate how SOD1 modifications and familial ALS mutations affect the interactions with Rac1, which is the goal of this supplement.
PUBLIC HEALTH RELEVANCE: The goal of the proposed work is to define a mechanism for the regulation of Rac1 by SOD1. Knowledge of this mechanism will lead to strategies for determining whether this new regulatory role of SOD1 is related to ALS. Furthermore if the Rac1/SOD1 the Rac1/SOD1 complex and contribute to ALS therapies.
描述(由申请人提供):抗氧化酶Cu,Zn超氧化物歧化酶(SOD1)通过一百多个致病突变与肌萎缩性侧索硬化症(ALS)有关。 Rac1 GTPase通过调节NADPH氧化酶(NOX)活性来调节氧化剂水平。有趣的是,最近显示SOD1以核苷酸和氧化还原依赖的方式结合Rac1来调节Rac1活性。此外,SOD1中的两个与ALS相关的突变显示出对氧化还原调节不敏感的SOD1/RAC1相互作用,据说通过NOX过度活跃会导致氧化剂水平升高。但是,此前提是基于仅从两个细菌衍生的突变体获得的有限定性结果。与在酿酒酵母中表达的天然SOD1和人类SOD1不同,大肠杆菌衍生的人类SOD1缺乏N末端乙酰化和适当的金属化。此外,我们最近发现,人类红细胞中的40-50%的SOD1被谷胱甘肽(谷胱甘肽)修改 - 谷胱甘肽是细胞氧化还原状态的关键参与者。谷胱甘肽促进了SOD1二聚体解离,这是SOD1聚集的必要启动事件,也是父求的重点。在这里,我们旨在使用从人类的红细胞和酿酒酵母中分离出的SOD1,对SOD1/RAC1相互作用及其与ALS的拟议关系进行定量描述。我们将使用NMR和其他生物物理技术来表征和量化RAC1/SOD1在存在和不存在SOD1中与ALS相关的突变的情况下进行的Rac1/SOD1相互作用。最近发现SOD1通过RAC1与NOX复合物相互作用的发现提供了SOD1(DYS)功能与导致细胞死亡的下游事件之间的潜在联系。因此,重要的是要描述SOD1修饰和家族性ALS突变如何影响与Rac1的相互作用,这是该补充的目的。
公共卫生相关性:拟议工作的目的是定义SOD1对RAC1进行调控的机制。对这种机制的了解将导致确定SOD1的新调节作用是否与ALS有关的策略。此外,如果Rac1/SOD1 Rac1/SOD1复合物并有助于ALS疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NIKOLAY DOKHOLYAN其他文献
NIKOLAY DOKHOLYAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NIKOLAY DOKHOLYAN', 18)}}的其他基金
AI-based Mapping of Complex Cannabis Extracts in Pain Pathways
基于人工智能的疼痛通路中复杂大麻提取物的绘图
- 批准号:
10659413 - 财政年份:2023
- 资助金额:
$ 28.83万 - 项目类别:
Discovery of functionally selective dopamine ligands for age-related cognitive decline
发现功能选择性多巴胺配体治疗与年龄相关的认知衰退
- 批准号:
10183430 - 财政年份:2021
- 资助金额:
$ 28.83万 - 项目类别:
Nanoscale programming of cellular and physiological phenotypes: Equipment
细胞和生理表型的纳米级编程:设备
- 批准号:
10382641 - 财政年份:2020
- 资助金额:
$ 28.83万 - 项目类别:
Nanoscale programing of cellular and physiological phenotypes
细胞和生理表型的纳米级编程
- 批准号:
10543756 - 财政年份:2020
- 资助金额:
$ 28.83万 - 项目类别:
Nanoscale programing of cellular and physiological phenotypes
细胞和生理表型的纳米级编程
- 批准号:
10320006 - 财政年份:2020
- 资助金额:
$ 28.83万 - 项目类别:
Integrating cheminformatics and molecular simulations for virtual drug screening
整合化学信息学和分子模拟进行虚拟药物筛选
- 批准号:
8858750 - 财政年份:2016
- 资助金额:
$ 28.83万 - 项目类别:
Immunogen Design to Target Carbohydrate-Occluded Epitopes on the HIV envelope
针对 HIV 包膜上碳水化合物封闭表位的免疫原设计
- 批准号:
8496715 - 财政年份:2012
- 资助金额:
$ 28.83万 - 项目类别:
Immunogen Design to Target Carbohydrate-Occluded Epitopes on the HIV envelope
针对 HIV 包膜上碳水化合物封闭表位的免疫原设计
- 批准号:
8681357 - 财政年份:2012
- 资助金额:
$ 28.83万 - 项目类别:
Immunogen Design to Target Carbohydrate-Occluded Epitopes on the HIV envelope
针对 HIV 包膜上碳水化合物封闭表位的免疫原设计
- 批准号:
8860109 - 财政年份:2012
- 资助金额:
$ 28.83万 - 项目类别:
Immunogen Design to Target Carbohydrate-Occluded Epitopes on the HIV envelope
针对 HIV 包膜上碳水化合物封闭表位的免疫原设计
- 批准号:
8410243 - 财政年份:2012
- 资助金额:
$ 28.83万 - 项目类别:
相似国自然基金
线上民宿房东亲和力对房客预定行为的影响机制研究——基于多源异构数据视角
- 批准号:72202154
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
线上民宿房东亲和力对房客预定行为的影响机制研究——基于多源异构数据视角
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
估计和解释序列变体对蛋白质稳定性、结合亲和力以及功能的影响
- 批准号:31701136
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
RGS19对嗜酸细胞性食管炎FcεRI信号传导通路的影响及其作用机制的研究
- 批准号:81500502
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
人B组腺病毒纤毛蛋白与DSG2受体亲和力的差异及其对病毒致病力的影响研究
- 批准号:31570163
- 批准年份:2015
- 资助金额:62.0 万元
- 项目类别:面上项目
相似海外基金
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
- 批准号:
10726763 - 财政年份:2023
- 资助金额:
$ 28.83万 - 项目类别:
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:
10727268 - 财政年份:2023
- 资助金额:
$ 28.83万 - 项目类别:
"Post-translational modification of non-histone proteins as a mechanism of pMHC-I neo-ligand generation"
“非组蛋白蛋白的翻译后修饰作为 pMHC-I 新配体生成的机制”
- 批准号:
10435184 - 财政年份:2022
- 资助金额:
$ 28.83万 - 项目类别:
Determination of Hair Cell Fate from Postnatal Cochlear Supporting Cells
产后耳蜗支持细胞毛细胞命运的测定
- 批准号:
10617788 - 财政年份:2022
- 资助金额:
$ 28.83万 - 项目类别:
Determination of Hair Cell Fate from Postnatal Cochlear Supporting Cells
产后耳蜗支持细胞毛细胞命运的测定
- 批准号:
10435013 - 财政年份:2022
- 资助金额:
$ 28.83万 - 项目类别: